AI assistant
Sending…
Ascelia Pharma — Major Shareholding Notification 2021
Dec 21, 2021
3132_iss_2021-12-21_249f05f1-e030-4d63-8af9-fc3b39f10895.pdf
Major Shareholding Notification
Open in viewerOpens in your device viewer
Issuer Ascelia Pharma AB
Holder
Fjärde AP-fonden
Instrument
| Instrument | Aktie | |||
|---|---|---|---|---|
| Before the transaction | ||||
| Shares | 1,641,841 | |||
| Voting rights | 1,641,841 | |||
| Transaction | ||||
| Date | 20/12/2021 | |||
| Limit for number of shares 5 % | ||||
| Limit for number of votes | 5 % |
After the transaction
Quantity
| Shares | 2,209,266 |
|---|---|
| Directly held voting rights 2,209,266 | |
| Indirectly held voting rights 0 |
Percentage
Directly held shares 6.39 % Directly held voting rights 6.54 % Indirectly held voting rights 0 %
Resulting distribution of total
| holdings | ||
|---|---|---|
| Percentage of voting rights: |
Number of underlying shares: |
|
| Shares | 6.54 % | 2,209,266 |
| Instruments - FITA Ch. 4, section 2, first paragraph, line 2 Instruments - FITA Ch. 4, section 2, first paragraph, line 3 |
||
| - Physically settled | ||
| - Cash settled | ||
| Total | 6.54 % | 2,209,266 |
| Group total holdings | ||
| Voting rights 2,209,266 |
||
| Percentage of voting rights 6.54 | ||
| Published | ||
| 21/12/2021 10:28 | ||
| Contact | ||
| Name Jannis Kitsakis |
||
| Phone 070-6038023 Email [email protected] |
||
[email protected] Tfn 08-408 980 37 Fax 08-24 39 25
More from Ascelia Pharma
Interim / Quarterly Report
2026
May 12
Interim / Quarterly Report
2026
May 12
Regulatory Filings
2026
May 4
Regulatory Filings
2026
May 4
Regulatory Filings
2026
Apr 30
Regulatory Filings
2026
Apr 30
Share Issue/Capital Change
2026
Apr 23
Share Issue/Capital Change
2026
Apr 23
Annual Report (ESEF)
2026
Apr 9
Proxy Solicitation & Information Statement
2026
Mar 30